Literature DB >> 16002673

Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.

Sergio A Quezada1, Kathy Bennett, Bruce R Blazar, Alexander Y Rudensky, Shimon Sakaguchi, Randolph J Noelle.   

Abstract

Although it has been shown that CD4(+)CD25(+) regulatory T cells (T(reg)) contribute to long-term graft acceptance, their impact on the effector compartment and the mechanism by which they exert suppression in vivo remain unresolved. Using a CD4(+) TCR transgenic model for graft tolerance, we have unveiled the independent contributions of anergy and active suppression to the fate of immune and tolerant alloreactive T cells in vivo. First, it is shown that anti-CD154-induced tolerance resulted in the abortive expansion of the alloreactive, effector T cell pool. Second, commensurate with reduced expansion, there was a loss of cytokine production, activation marker expression, and absence of memory T cell markers. All these parameters defined the tolerant alloreactive T cells and correlated with the inability to mediate graft rejection. Third, the tolerant alloreactive T cell phenotype that is induced by CD154 was reversed by the in vivo depletion of T(reg). Reversal of the tolerant phenotype was followed by rapid rejection of the allograft. Fourth, in addition to T(reg) depletion, costimulation of the tolerant alloreactive T cells or activation of the APC compartment also reverted alloreactive T cell tolerance and restored an activated phenotype. Finally, it is shown that the suppression is long-lived, and in the absence of anti-CD154 and donor-specific transfusion, these T(reg) can chronically suppress effector cell responses, allowing long-lived graft acceptance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002673     DOI: 10.4049/jimmunol.175.2.771

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade.

Authors:  Ivana R Ferrer; Maylene E Wagener; Minqing Song; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Human and murine obliterative bronchiolitis in transplant.

Authors:  John F McDyer
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus.

Authors:  Adrian Erlebacher; Daniela Vencato; Kelly A Price; Dorothy Zhang; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

Review 4.  Changing paradigms in the immunological science of allergy.

Authors:  Edward J Goetzl
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

Review 5.  Inhibitory costimulation and anti-tumor immunity.

Authors:  Natalia Martin-Orozco; Chen Dong
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

6.  Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

Authors:  Nicolas Degauque; Christophe Mariat; James Kenny; Dong Zhang; Wenda Gao; Minh Diem Vu; Sophoclis Alexopoulos; Mohammed Oukka; Dale T Umetsu; Rosemarie H DeKruyff; Vijay Kuchroo; Xin Xiao Zheng; Terry B Strom
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 7.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

8.  Long-term control of alloreactive B cell responses by the suppression of T cell help.

Authors:  Yijin Li; Lianli Ma; Dengping Yin; JiKun Shen; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

Authors:  David C Gondek; Victor Devries; Elizabeth C Nowak; Li-Fan Lu; Kathryn A Bennett; Zachary A Scott; Randolph J Noelle
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 10.  Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.

Authors:  David F Pinelli; Mandy L Ford
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.